Biosolutions Inc. Emergent serves as Executive at Aptevo Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Biosolutions Inc. Emergent has executed 4 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Aug 1, 2016 involved transacting 20,230,074 shares valued at $0.
Biosolutions Inc. Emergent currently holds 20,230,074 shares of Aptevo Therapeutics Inc. (APVO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Biosolutions Inc. Emergent has been a net neutral trader of APVO stock. They have purchased $0 and sold $0 worth of shares.
Biosolutions Inc. Emergent's most recent insider trade was on Aug 1, 2016, when they sold 20,230,074 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jul 29, 2016 | APVO | $0 | Other | 20,229,074 | $N/A | Discretionary |
| Jul 29, 2016 | APVO | $0 | Other | 20,228,849 | $N/A | Discretionary |